Add to ORKGThe Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Clinical trials have shown that liraglutide effectively lowers glycated hemoglobin A1c (A1C) levels in adult patients with type 2 diabetes (T2D). However, no studies have evaluated the effectiveness of liraglutid
Objectives: This study assessed the effect of liraglutide as a monotherapy and add-on to metformin o...
The GLP-1 receptor agonist Liraglutide is effective in reducing HbA1c in type 2 diabetic (T2D) patie...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...
Alanoud Aladel, Jamilah Aljaouni, Reem Basaad Department of Community Health Sciences, College of Ap...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: In ...
Item does not contain fulltextBACKGROUND: Pronounced weight gain frequently complicates insulin ther...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...
Copyright © 2012 Takamasa Ohki et al. This is an open access article distributed under the Creative ...
Aims: To compare real-world antidiabetic treatment outcomes over 12 months in obese people with type...
Background: Long-term efficacy of liraglutide, a glucagon-like peptide-1 analog, on body weight and ...
Introduction: The aim of the present study was to use real-world data from Swedish primary-care and ...
IMPORTANCE: Weight loss of 5% to 10% can improve type 2 diabetes and related comorbidities. Few safe...
The Author(s) 2015. This article is published with open access at Springerlink.com Objectives: Metfo...
Mahamood Edavalath1, Jeffrey W Stephens1,21Department of Diabetes and Endocrinology, Morriston Hospi...
Context: GLP-1 receptor agonists (GLP-1 RA) are unique antidiabetic agents that have the ability to ...
Objectives: This study assessed the effect of liraglutide as a monotherapy and add-on to metformin o...
The GLP-1 receptor agonist Liraglutide is effective in reducing HbA1c in type 2 diabetic (T2D) patie...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...
Alanoud Aladel, Jamilah Aljaouni, Reem Basaad Department of Community Health Sciences, College of Ap...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: In ...
Item does not contain fulltextBACKGROUND: Pronounced weight gain frequently complicates insulin ther...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...
Copyright © 2012 Takamasa Ohki et al. This is an open access article distributed under the Creative ...
Aims: To compare real-world antidiabetic treatment outcomes over 12 months in obese people with type...
Background: Long-term efficacy of liraglutide, a glucagon-like peptide-1 analog, on body weight and ...
Introduction: The aim of the present study was to use real-world data from Swedish primary-care and ...
IMPORTANCE: Weight loss of 5% to 10% can improve type 2 diabetes and related comorbidities. Few safe...
The Author(s) 2015. This article is published with open access at Springerlink.com Objectives: Metfo...
Mahamood Edavalath1, Jeffrey W Stephens1,21Department of Diabetes and Endocrinology, Morriston Hospi...
Context: GLP-1 receptor agonists (GLP-1 RA) are unique antidiabetic agents that have the ability to ...
Objectives: This study assessed the effect of liraglutide as a monotherapy and add-on to metformin o...
The GLP-1 receptor agonist Liraglutide is effective in reducing HbA1c in type 2 diabetic (T2D) patie...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...